LPL Financial’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Sell |
52,503
-15,220
| -22% | -$31.5K | ﹤0.01% | 5105 |
|
|
2025
Q1 | $149K | Buy |
67,723
+9,625
| +17% | +$21.2K | ﹤0.01% | 4816 |
|
|
2024
Q4 | $88.9K | Sell |
58,098
-7,559
| -12% | -$11.6K | ﹤0.01% | 4894 |
|
|
2024
Q3 | $131K | Buy |
65,657
+325
| +0.5% | +$647 | ﹤0.01% | 4731 |
|
|
2024
Q2 | $229K | Buy |
65,332
+13,941
| +27% | +$48.8K | ﹤0.01% | 4374 |
|
|
2024
Q1 | $142K | Buy |
51,391
+23,038
| +81% | +$63.8K | ﹤0.01% | 4516 |
|
|
2023
Q4 | $48.2K | Sell |
28,353
-4,342
| -13% | -$7.38K | ﹤0.01% | 4589 |
|
|
2023
Q3 | $33.7K | Sell |
32,695
-830
| -2% | -$855 | ﹤0.01% | 4504 |
|
|
2023
Q2 | $38.9K | Buy |
33,525
+20,575
| +159% | +$23.9K | ﹤0.01% | 4399 |
|
|
2023
Q1 | $19.6K | Buy |
12,950
+1,000
| +8% | +$1.51K | ﹤0.01% | 4381 |
|
|
2022
Q4 | $29.9K | Sell |
11,950
-2,000
| -14% | -$5K | ﹤0.01% | 4304 |
|
|
2022
Q3 | $59K | Sell |
13,950
-1,100
| -7% | -$4.65K | ﹤0.01% | 4176 |
|
|
2022
Q2 | $42K | Sell |
15,050
-1,450
| -9% | -$4.05K | ﹤0.01% | 4225 |
|
|
2022
Q1 | $94K | Buy |
16,500
+250
| +2% | +$1.42K | ﹤0.01% | 3971 |
|
|
2021
Q4 | $148K | Buy |
16,250
+1,307
| +9% | +$11.9K | ﹤0.01% | 4047 |
|
|
2021
Q3 | $160K | Sell |
14,943
-5,522
| -27% | -$59.1K | ﹤0.01% | 4020 |
|
|
2021
Q2 | $318K | Buy |
20,465
+5,265
| +35% | +$81.8K | ﹤0.01% | 3535 |
|
|
2021
Q1 | $246K | Buy |
15,200
+2,990
| +24% | +$48.4K | ﹤0.01% | 3594 |
|
|
2020
Q4 | $258K | Sell |
12,210
-9,573
| -44% | -$202K | ﹤0.01% | 3317 |
|
|
2020
Q3 | $323K | Buy |
21,783
+3,125
| +17% | +$46.3K | ﹤0.01% | 2836 |
|
|
2020
Q2 | $274K | Buy |
+18,658
| New | +$274K | ﹤0.01% | 2880 |
|
|
2018
Q3 | – | Sell |
-6,144
| Closed | -$239K | – | 3245 |
|
|
2018
Q2 | $239K | Buy |
+6,144
| New | +$239K | ﹤0.01% | 2836 |
|